11 research outputs found
Escherichia coli J5: imunização de fêmeas bovinas leiteiras contra mastites causadas por Escherichia coli
Mastite subclínica e relação da contagem de células somáticas com número de lactações, produção e composição química do leite em vacas da raça Holandesa
Partial budget analysis of prepartum antimicrobial therapy and Escherichia coli J5 vaccination of dairy heifers and their effect on milk production and milk quality parameters
Utilização da vacina Escherichia coli J5 na imunização de novilhas leiteiras contra mastites causadas por E. coli
Avaliou-se a eficácia da vacina E.coli J5 na prevenção e no controle de mastites causadas por E.coli por meio da análise da prevalência de infecções intramamárias após o parto, ocorrência e intensidade de casos clínicos de mastite nos primeiros 100 dias de lactação, influência na contagem de células somáticas (CCS) e produção de leite. As novilhas, n=131, foram distribuídas em três grupos de animais - vacinados três vezes, vacinados duas vezes e não vacinados. As imunizações ocorreram 60 dias antes do parto, 30 dias antes do parto e na primeira semana pós-parto, esta última só para o grupo de três vacinações. Foram coletadas amostras de leite para diagnóstico microbiológico e avaliação da CCS, e registrados os dados relacionados à ocorrência e à intensidade dos casos clínicos e à produção de leite nos primeiros 100 dias de lactação. Não houve redução na prevalência de E.coli no pós-parto de novilhas vacinadas, e houve redução na ocorrência de casos clínicos por E.coli em novilhas vacinadas. Não foram observadas diferenças entre grupos com relação à CCS. Novilhas vacinadas com as três doses apresentaram maior produção de leite. A vacinação com E.coli J5 foi eficaz em reduzir a ocorrência de casos clínicos nos primeiros 100 dias da lactação, mas não interferiu na prevalência de infecções intramamárias após o parto, na intensidade de casos clínicos e na CCS
Mastite subclínica e relação da contagem de células somáticas com número de lactações, produção e composição química do leite em vacas da raça Holandesa Subclinical mastitis and the relationship between somatic cell count with number of lactations, production and chemical composition of the milk
Verificaram-se a ocorrência de mastite subclínica em animais da raça Holandesa e a relação entre a contagem de células somáticas com a ordem de lactação e com a produção e a composição química do leite. O estudo foi realizado em propriedades integrantes do programa de controle leiteiro da Associação de Criadores de Gado Holandês de Minas Gerais. As variáveis estudadas foram: ordem de lactação, ocorrência de mastite subclínica, contagem de células somáticas (CCS), produção de leite e porcentagens de gordura e de proteína total. A correlação entre CCS e produção de leite foi negativa e entre CCS e porcentagens de gordura e de proteína, positivas. Animais com maior número de lactações apresentaram maior CCS, e com CCS acima de 100.000 cels/ml menor produção de leite.The subclinical mastitis occurrence and the relationship between somatic cell count (SCC) with parity, milk yield and milk chemical composition, were studied in Holstein cows. The study was carried out in farms belonging to the milk control program of the Associação de Criadores de Gado Holandês de Minas Gerais. Data on lactation order, subclinical mastitis, SCC, milk production, fat contents and total protein contents were analyzed. There was a negative correlation between SCC and milk production and, correlations between SCC and percentage of fat and protein were positive. Higher lactation order cows showed higher SCC, and cows with SCC higher than 100,000 cels/ml showed less milk production
Vacinação com Escherichia coli J5 no pré-parto e ocorrência de mastite e produção de leite de vacas mestiças leiteiras
Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer
Background: Pelvic exenteration for locally recurrent rectal cancer (LRRC) is associated with variable outcomes, with the majority of data from single-centre series. This study analysed data from an international collaboration to determine robust parameters that could inform clinical decision-making. Methods: Anonymized data on patients who had pelvic exenteration for LRRC between 2004 and 2014 were accrued from 27 specialist centres. The primary endpoint was survival. The impact of resection margin, bone resection, node status and use of neoadjuvant therapy (before exenteration) was assessed. Results: Of 1184 patients, 614 (51\ub79 per cent) had neoadjuvant therapy. A clear resection margin (R0 resection) was achieved in 55\ub74 per cent of operations. Twenty-one patients (1\ub78 per cent) died within 30 days and 380 (32\ub71 per cent) experienced a major complication. Median overall survival was 36 months following R0 resection, 27 months after R1 resection and 16 months following R2 resection (P < 0\ub7001). Patients who received neoadjuvant therapy had more postoperative complications (unadjusted odds ratio (OR) 1\ub753), readmissions (unadjusted OR 2\ub733) and radiological reinterventions (unadjusted OR 2\ub712). Three-year survival rates were 48\ub71 per cent, 33\ub79 per cent and 15 per cent respectively. Bone resection (when required) was associated with a longer median survival (36 versus 29 months; P < 0\ub7001). Node-positive patients had a shorter median overall survival than those with node-negative disease (22 versus 29 months respectively). Multivariable analysis identified margin status and bone resection as significant determinants of long-term survival. Conclusion: Negative margins and bone resection (where needed) were identified as the most important factors influencing overall survival. Neoadjuvant therapy before pelvic exenteration did not affect survival, but was associated with higher rates of readmission, complications and radiological reintervention
Minimally invasive surgery techniques in pelvic exenteration: a systematic and meta-analysis review
Background: Pelvic exenteration is potentially curative for locally advanced and recurrent pelvic cancers. Evolving technology has facilitated the use of minimally invasive surgical (MIS) techniques in selected cases. We aimed to compare outcomes between open and MIS pelvic exenteration. Methods: A review of comparative studies was performed. Firstly, we evaluated the differences in surgical techniques with respect to operative time, blood loss, and margin status. Secondly, we assessed differences in 30-day morbidity and mortality rates, and length of hospital stay. Results: Four studies that directly compared open and MIS exenteration were included. Analysis was performed on 170 patients; 78.1% (n = 133) had open pelvic exenteration, while 21.8% (n = 37) had a MIS exenteration. The median age for open exenteration was 57.7 years versus 63 years for MIS exenteration. Even though the operative time for MIS exenteration was 83 min longer (p < 0.001), it was associated with a median of 1,750mls less blood loss. The morbidity rate for MIS exenterative group was 56.7% (n = 21/37) versus 88.5% (n = 85/96) in the open exenteration group, with pooled analysis observing a 1.17 relative risk increase in 30-day morbidity (p = 0.172) in the open exenteration group. In addition, the MIS cohort had a 6-day shorter length of hospital stay (p = 0.04). Conclusion: MIS exenteration can be performed in highly selective cases, where there is favourable patient anatomy and tumour characteristics. When feasible, it is associated with reduced intra-operative blood loss, shorter length of hospital stay, and reduced morbidity
Palliative pelvic exenteration: A systematic review of patient-centered outcomes
Objective: Palliative pelvic exenteration (PPE) is a technically complex operation with high morbidity and mortality rates, considered in patients with limited life expectancy. There is little evidence to guide practice. We performed a systematic review to evaluate the impact of PPE on symptom relief and quality of life (QoL). Methods: A systematic review was conducted according to the PRISMA guidelines using Ovid MEDLINE, EMBASe, and PubMed databases for studies reporting on outcomes of PPE for symptom relief or QoL. Descriptive statistics were used on pooled patient cohorts. Results: Twenty-three historical cohorts and case series were included, comprising 509 patients. No comparative studies were found. Most malignancies were of colorectal, gynaecological and urological origin. Common indications for PPE were pain, symptomatic fistula, bleeding, malodour, obstruction and pelvic sepsis. The pooled median postoperative morbidity rate was 53.6% (13\u2013100%), the median in-hospital mortality was 6.3% (0\u201366.7%), and median OS was 14 months (4\u201340 months). Some symptom relief was reported in a median of 79% (50\u2013100%) of the patients, although the magnitude of effect was poorly measured. Data for QoL measures were inconclusive. Five studies discouraged performing PPE in any patient, while 18 studies concluded that the procedure can be considered in highly selected patients. Conclusion: Available evidence on PPE is of low-quality. Morbidity and mortality rates are high with a short median OS interval. While some symptom relief may be afforded by this procedure, evidence for improvement in QoL is limited. A highly selective individualised approach is required to optimise the risk:benefit equation
Predicting outcomes of pelvic exenteration using machine learning
Aim: We aim to compare machine learning with neural network performance in predicting R0 resection (R0), length of stay > 14 days (LOS), major complication rates at 30 days postoperatively (COMP) and survival greater than 1 year (SURV) for patients having pelvic exenteration for locally advanced and recurrent rectal cancer. Method: A deep learning computer was built and the programming environment was established. The PelvEx Collaborative database was used which contains anonymized data on patients who underwent pelvic exenteration for locally advanced or locally recurrent colorectal cancer between 2004 and 2014. Logistic regression, a support vector machine and an artificial neural network (ANN) were trained. Twenty per cent of the data were used as a test set for calculating prediction accuracy for R0, LOS, COMP and SURV. Model performance was measured by plotting receiver operating characteristic (ROC) curves and calculating the area under the ROC curve (AUROC). Results: Machine learning models and ANNs were trained on 1147 cases. The AUROC for all outcome predictions ranged from 0.608 to 0.793 indicating modest to moderate predictive ability. The models performed best at predicting LOS > 14 days with an AUROC of 0.793 using preoperative and operative data. Visualized logistic regression model weights indicate a varying impact of variables on the outcome in question. Conclusion: This paper highlights the potential for predictive modelling of large international databases. Current data allow moderate predictive ability of both complex ANNs and more classic methods